Ultima Genomics, Inc.
Fremont, CA
- UEI
- DXEVRGJ7MW28
- CAGE
- 84C26
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 4209 Technology Dr, Fremont, CA 94538, USA
- Website
- ultimagenomics.com
- Founded
- 2016
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $166,358 |
Contract awards
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Twinstrand Biosciences Inc. | Seattle, WA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Dovetail Genomics LLC | Scotts Valley, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Illumina, Inc. | San Diego, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| Medgenome Inc. | Foster City, CA | 621511 Medical Laboratories |
| Seqwell Inc. | Beverly, MA | 325414 Biological Product (except Diagnostic) Manufacturing |
About the company
Ultima Genomics, Inc. is a for-profit corporate entity based in Fremont, California, specializing in advanced DNA sequencing technology and genomic research solutions. The company has developed the UG100 platform, which aims to provide scalable and cost-effective genome sequencing, with a goal of reducing the cost of nucleic acid sequencing to approximately $100 per genome. Registered in SAM.gov since May 24, 2018, Ultima Genomics has established itself as an innovative manufacturer of high-throughput DNA sequencing instruments and reagents, primarily serving research institutions and federal agencies in the biomedical research sector.
The company has secured multiple federal contract awards from prominent agencies including the National Human Genome Research Institute (NHGRI) and the National Institute of Allergy and Infectious Diseases (NIAID). These contracts, ranging from $19,858 to $1,025,000, have primarily involved the procurement of DNA sequencing reagents and advanced sequencing equipment like the UG100-V DNA sequencer. None of the contracts were set aside for specific business categories, and they were awarded as firm-fixed-price purchase orders. The contracts support critical research initiatives, such as the "Project Kastner NF GRASP" and vaccine research at the NIH Vaccine Research Center, which requires processing over 9 terabytes of genomic data daily. The contract awards demonstrate Ultima Genomics' capability to provide cutting-edge genomic research tools that enable high-throughput sequencing and advanced scientific investigation across various biomedical research domains.
Quick answers
Is Ultima Genomics, Inc. registered in SAM.gov?
Yes. Ultima Genomics, Inc.'s SAM.gov registration is active through March 9, 2027.
How much has Ultima Genomics, Inc. received in federal contracts?
Federal contracts obligated $166,358 to Ultima Genomics, Inc. in fiscal year 2025.
How does Ultima Genomics, Inc. rank among federal contractors?
Ultima Genomics, Inc. ranked #75 in PSC 6550 in FY2025.
What is Ultima Genomics, Inc.'s most recent federal award?
Ultima Genomics, Inc.'s most recent federal contract award is Purchase of ultima genomics reagents, new PO (75N92025P00333), from National Heart Lung and Blood Institute (NIH), on September 1, 2025.
On GovTribe
See Ultima Genomics, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors